Publikationen, an denen er mitarbeitet Miguel Alcoceba Sánchez (16)

2021

  1. The novel HLA-DQB1*06:03:27 allele characterised by sequence-based typing in a European bone marrow donor

    HLA, Vol. 98, Núm. 5, pp. 498-500

2018

  1. Unraveling the heterogeneity of IgM monoclonal gammopathies: a gene mutational and gene expression study

    Annals of Hematology, Vol. 97, Núm. 3, pp. 475-484

2017

  1. From Waldenström's macroglobulinemia to aggressive diffuse large B-cell lymphoma: A whole-exome analysis of abnormalities leading to transformation

    Blood Cancer Journal, Vol. 7, Núm. 8

2016

  1. High-resolution copy number analysis of paired normal-tumor samples from diffuse large B cell lymphoma

    Annals of Hematology, Vol. 95, Núm. 2, pp. 253-262

2015

  1. The predominant myeloma clone at diagnosis, CDR3 defined, is constantly detectable across all stages of disease evolution

    Leukemia

2014

  1. Critical evaluation of ASO RQ-PCR for minimal residual disease evaluation in multiple myeloma. A comparative analysis with flow cytometry

    Leukemia, Vol. 28, Núm. 2, pp. 391-397

  2. Detection of MYD88 L265P mutation by real-time allele-specific oligonucleotide polymerase chain reaction

    Applied Immunohistochemistry and Molecular Morphology, Vol. 22, Núm. 10, pp. 768-773

2013

  1. HLA specificities are related to development and prognosis of diffuse large B-cell lymphoma

    Blood, Vol. 122, Núm. 8, pp. 1448-1454

  2. MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström's macroglobulinemia

    Leukemia, Vol. 27, Núm. 8, pp. 1722-1728

  3. The use of CD138 positively selected marrow samples increases the applicability of minimal residual disease assessment by PCR in patients with multiple myeloma

    Annals of Hematology, Vol. 92, Núm. 1, pp. 97-100

2012

  1. Molecular characterization of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma: Antigen-driven origin and IGHV4-34 as a particular subgroup of the non-GCB subtype

    American Journal of Pathology, Vol. 181, Núm. 5, pp. 1879-1888

2011

  1. Frequency of HLA-A, -B and -DRB1 specificities and haplotypic associations in the population of Castilla y León (northwest-central Spain)

    Tissue Antigens, Vol. 78, Núm. 4, pp. 249-255

2010

  1. Long FLT3 internal tandem duplications and reduced PML-RARα expression at diagnosis characterize a high-risk subgroup of acute promyelocytic leukemia patients

    Haematologica, Vol. 95, Núm. 5, pp. 745-751

2008

  1. Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytoehrome P450 CYP2C8 in multiple myeloma: A genome-wide single nucleotide polymorphism analysis

    Blood, Vol. 112, Núm. 7, pp. 2709-2712

  2. Clinical and prognostic value of discrepancies in microsatellite dna regions between recipient and donor in human leukocyte antigen-identical allogeneic transplantation setting

    Transplantation, Vol. 86, Núm. 7, pp. 983-990

  3. The presence of DRB1*01 allele in multiple myeloma patients is associated with an indolent disease

    Tissue Antigens, Vol. 71, Núm. 6, pp. 548-551